Carla S. Saad

Av. Dr Arnaldo, 455 3°. Andar Cerqueira César, 01246-903
Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Spondyloarthritis in Indigenous Populations: How Classification Shapes Epidemiology.

Spondyloarthritis in Indigenous Populations: How Classification Shapes Epidemiology.

Journal: The Journal of rheumatology

Published: July 15, 2026

Safety and effectiveness of rituximab biosimilar (Rituximab-GP2013) versus originator in rheumatoid arthritis: real-world evidence from a single center.

Safety and effectiveness of rituximab biosimilar (Rituximab-GP2013) versus originator in rheumatoid arthritis: real-world evidence from a single center.

Journal: Clinics (Sao Paulo, Brazil)

Published: March 20, 2026

Impact of sex in axial spondyloarthritis: insights from the Brazilian Registry of Spondyloarthritis.

Impact of sex in axial spondyloarthritis: insights from the Brazilian Registry of Spondyloarthritis.

Journal: Advances in rheumatology (London, England)

Published: August 24, 2025

Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority study.

Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority study.

Journal: The Lancet. Rheumatology

Published: July 26, 2025

Efficacy of switching from originator adalimumab to biosimilar adalimumab-AACF in patients with rheumatoid arthritis: a 12-month observational study.

Efficacy of switching from originator adalimumab to biosimilar adalimumab-AACF in patients with rheumatoid arthritis: a 12-month observational study.

Journal: Advances in rheumatology (London, England)

Published: March 07, 2025

Disease Safety, Immunogenicity, and Efficacy of Recombinant Herpes Zoster Vaccine (RZV or Shingrix) in Autoimmune Rheumatic Diseases: Launching a Randomized Phase 4 Study.

Disease Safety, Immunogenicity, and Efficacy of Recombinant Herpes Zoster Vaccine (RZV or Shingrix) in Autoimmune Rheumatic Diseases: Launching a Randomized Phase 4 Study.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: October 09, 2024

Position statement of the Biotechnology Committee of the Brazilian Society of Rheumatology on the interchangeability of originator and biosimilar biologics in immune-mediated rheumatic diseases.

Position statement of the Biotechnology Committee of the Brazilian Society of Rheumatology on the interchangeability of originator and biosimilar biologics in immune-mediated rheumatic diseases.

Journal: Advances in rheumatology (London, England)

Published: October 06, 2024

The Assessment of SpondyloArthritis International Society (ASAS) Consensus-Based Expert Definition of Difficult-to-Manage, including Treatment-Refractory, Axial Spondyloarthritis.

The Assessment of SpondyloArthritis International Society (ASAS) Consensus-Based Expert Definition of Difficult-to-Manage, including Treatment-Refractory, Axial Spondyloarthritis.

Journal: Annals of the rheumatic diseases

Published: September 18, 2024

Reply.

Reply.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: July 12, 2024

To be or not to B27 positive: implications for the phenotypes of axial spondyloarthritis outcomes. Data from a large multiracial cohort from the Brazilian Registry of Spondyloarthritis.

To be or not to B27 positive: implications for the phenotypes of axial spondyloarthritis outcomes. Data from a large multiracial cohort from the Brazilian Registry of Spondyloarthritis.

Journal: Advances in rheumatology (London, England)

Published: March 21, 2024

Tuberculin skin test repetition after TNF-α inhibitors in patients with chronic inflammatory arthritis: a long-term retrospective cohort in endemic area.

Tuberculin skin test repetition after TNF-α inhibitors in patients with chronic inflammatory arthritis: a long-term retrospective cohort in endemic area.

Journal: Advances in rheumatology (London, England)

Published: January 29, 2024

Long-Term Follow-Up of Anti-Infliximab Antibodies in Patients With Radiographic Axial Spondyloarthritis: A Marker of Drug Survival and Tapering.

Long-Term Follow-Up of Anti-Infliximab Antibodies in Patients With Radiographic Axial Spondyloarthritis: A Marker of Drug Survival and Tapering.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: September 14, 2023

Showing 1-12 of 51

Last Updated: 09/26/2026